Commercial insight into the pharma and biotech sector.
Sales by Indication
EvaluatePharma®'s groundbreaking Sales by Indication analysis means you can easily identify the leading indications and uncover new market opportunities.
Determining which indications are most valuable can be challenging but our unique Sales by Indication reports cover the products driving the future of the industry, giving you the insights you need for early strategic development of new indications.
Our Sales by Indication analysis provides indication-specific sales of a individual product, compiled mainly through equity analyst research and proprietary EvaluatePharma® methodolgies that you can rely on.
- Sales by Indication reveals the indication specific dynamic behind historic and forecast product sales
- Determine which indication is the most commercially important for a product
- Identify the leading products for an indication
- Find the value by indication, and the gaps, in a company's product portfolio
- Estimate the size of the branded market for a disease
Register for access to a selection of free analysis and insights